Hofs H P, McVie J G
Division of Medical Oncology, University Hospital Nijmegen, The Netherlands.
Invest New Drugs. 1991 Aug;9(3):227-32. doi: 10.1007/BF00176975.
New analogs of diflubenzuron, a benzoylphenyl urea, are tested on their in vitro cytostatic activity against B16 melanoma cells. The following structure-activity relationship was established: substitution by a hydroxylated function at the ortho, meta or para position or by a dimethylamino function at the ortho position of the benzoyl moiety appeared to be necessary for cytostatic activity in vitro. Acetoxy functions at the ortho position or hydroxy functions at the para position of the aniline ring resulted also in active compounds. A number of these benzoylphenyl ureas are selected for in vivo evaluation of antitumor activity on B16 melanoma growing s.c.. Although many of the tested benzoylphenyl ureas delayed tumor growth during the first ten days of drug treatment, only a few increased animal life span. The best results (% T/C) were obtained with compounds 5 (127%), 7 (147%), 13 (135%) and 16 (135%), which all have hydroxylated functions in the benzoyl moiety.
对苯甲酰基苯基脲类的新型氟虫脲类似物进行了体外抗B16黑色素瘤细胞的细胞生长抑制活性测试。建立了以下构效关系:在苯甲酰基部分的邻位、间位或对位被羟基化官能团取代,或在邻位被二甲基氨基官能团取代,似乎是体外细胞生长抑制活性所必需的。苯胺环的邻位乙酰氧基官能团或对位羟基官能团也产生了活性化合物。选择了一些此类苯甲酰基苯基脲进行体内对皮下生长的B16黑色素瘤的抗肿瘤活性评估。尽管许多测试的苯甲酰基苯基脲在药物治疗的前十天延迟了肿瘤生长,但只有少数增加了动物寿命。化合物5(127%)、7(147%)、13(135%)和16(135%)获得了最佳结果(%T/C),它们在苯甲酰基部分均具有羟基化官能团。